---
category: listing
circular_id: 7c9f42ff87ffa3e8
date: '2026-02-26'
description: 'NSE announces the forthcoming listing of Gaudium IVF and Women Health
  Limited (symbol: GAUDIUMIVF) on the exchange under ISIN INE0P8B01020. The exact
  listing date will be communicated via a separate circular.'
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML72989.pdf
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: This is a routine IPO listing notification for a mid-sized healthcare
  company. Impact is medium as it affects investors and members tracking new listings,
  but the actual listing date has not yet been confirmed.
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML72989.pdf
processing:
  attempts: 1
  content_hash: 653f707798718cc7
  processed_at: '2026-02-26T07:02:15.342317'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-02-26T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML72989.pdf
severity: medium
source: nse
stocks:
- GAUDIUMIVF
tags:
- ipo
- listing
- equity-shares
- gaudiumivf
- healthcare
- ivf
- women-health
title: Listing of Equity Shares of Gaudium IVF and Women Health Limited (IPO)
---

## Summary

NSE has issued a circular informing all exchange members about the forthcoming listing of equity shares of Gaudium IVF and Women Health Limited on the National Stock Exchange of India. The company will trade under the symbol **GAUDIUMIVF**. The specific date of listing will be communicated through a separate circular.

## Key Points

- Company name: Gaudium IVF and Women Health Limited
- Trading symbol: GAUDIUMIVF
- ISIN: INE0P8B01020
- Listing type: Initial Public Offering (IPO)
- Actual listing date to be announced via a separate circular
- Circular issued by NSE Listing Department (Ref: NSE/CML/72989, Circular Ref. No: 0323/2026)

## Regulatory Changes

No regulatory changes are introduced by this circular. It is a standard pre-listing notification as required under NSE listing procedures.

## Compliance Requirements

- All NSE members are hereby informed of the forthcoming listing and should prepare accordingly for trading in GAUDIUMIVF shares.
- Members should monitor for the follow-up circular that will confirm the exact listing date.

## Important Dates

- Circular Date: February 26, 2026
- Listing Date: To be announced via a separate circular

## Impact Assessment

This circular signals the imminent market debut of Gaudium IVF and Women Health Limited, a company operating in the fertility and women's healthcare sector. Investors and brokers should be prepared for trading activity upon the official listing date announcement. The listing is expected to attract interest from healthcare-focused investors. No immediate trading or compliance action is required until the listing date is formally announced.